Armando Perez De Prado

Dr. Armando Perez De Prado

Cardiology, Hospital de León, León, Castille-Leon, Spain
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Circulation
Verified
Journal Article
Closed access
BIBorja Ibanez
Borja Ibanez
CMCarlos Macaya
Carlos Macaya
VSVicente Sánchez-Brunete
Vicente Sánchez-Brunete
GPGonzalo Pizarro
Gonzalo Pizarro
LFLeticia Fernández-Friera
Leticia Fernández-Friera
VFValentin Fuster
Valentin Fuster
Background—: The effect of β-blockers on infarct size when used in conjunction with primary percutaneous coronary intervention is unknown. We hypothesize that metoprolol reduces infarct size when administered early (intravenously before reperfusion). Methods and Results—: Patients with Killip class II or less anterior ST-segment–elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention within 6 hours of symptoms onset were randomized to receive intravenous metoprolol (n=131) or not (control, n=139) before reperfusion. All patients without contraindications received oral metoprolol within 24 hours. The predefined primary end point was infarct size on magnetic resonance imaging performed 5 to 7 days after STEMI. Magnetic resonance imaging was performed in 220 patients (81%). Mean±SD infarct size by magnetic resonance imaging was smaller after intravenous metoprolol compared with control (25.6±15.3 versus 32.0±22.2 g; adjusted difference, −6.52; 95% confidence interval, −11.39 to −1.78; P =0.012). In patients with pre–percutaneous coronary intervention Thrombolysis in Myocardial Infarction grade 0 to 1 flow, the adjusted treatment difference in infarct size was −8.13 (95% confidence interval, −13.10 to −3.16; P =0.0024). Infarct size estimated by peak and area under the curve creatine kinase release was measured in all study populations and was significantly reduced by intravenous metoprolol. Left ventricular ejection fraction was higher in the intravenous metoprolol group (adjusted difference, 2.67%; 95% confidence interval, 0.09–5.21; P =0.045). The composite of death, malignant ventricular arrhythmia, cardiogenic shock, atrioventricular block, and reinfarction at 24 hours in the intravenous metoprolol and control groups was 7.1% and 12.3%, respectively ( P =0.21). Conclusions—: In patients with anterior Killip class II or less ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention, early intravenous metoprolol before reperfusion reduced infarct size and increased left ventricular ejection fraction with no excess of adverse events during the first 24 hours after STEMI. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01311700. EUDRACT number: 2010-019939-35.

1 March 2008 in JACC
Verified
Journal Article
Closed access
JTJosé M. de la Torre-Hernández
José M. de la Torre-Hernández
FAFernando Alfonso
Fernando Alfonso
FHFelipe Hernández
Felipe Hernández
JEJaime Elizaga
Jaime Elizaga
MSMarcelo Sanmartín
Marcelo Sanmartín
JMJosepa Mauri
Josepa Mauri

1 March 2014 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JHJose M. de la Torre Hernandez
Jose M. de la Torre Hernandez
JAJosé A. Baz Alonso
José A. Baz Alonso
JHJoan A. Gómez Hospital
Joan A. Gómez Hospital
FMFernando Alfonso Manterola
Fernando Alfonso Manterola
TCTamara Garcia Camarero
Tamara Garcia Camarero
JGJavier Zueco Gil
Javier Zueco Gil

1 July 2021 in JACC
Verified
Journal Article
Closed access
TSTrevor Simard
Trevor Simard
RJRichard G. Jung
Richard G. Jung
KLKyle Lehenbauer
Kyle Lehenbauer
KPKerstin Piayda
Kerstin Piayda
RPRadoslaw Pracoń
Radoslaw Pracoń
MAMohamad Alkhouli
Mohamad Alkhouli

1 August 2011 in JACC
Verified
Journal Article
Closed access
GEGeorgina M Ellison-Hughes
Georgina M Ellison-Hughes
DTDaniele Torella
Daniele Torella
SDSanto Dellegrottaglie
Santo Dellegrottaglie
CPClaudia C. Pérez-Martínez
Claudia C. Pérez-Martínez
APArmando Perez De Prado
Armando Perez De Prado
BNBernardo Nadal-Ginard
Bernardo Nadal-Ginard

1 December 2020 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
OROriol Rodríguez-Leor
Oriol Rodríguez-Leor
BCBelén Cid-Álvarez
Belén Cid-Álvarez
APArmando Perez De Prado
Armando Perez De Prado
XRXavier Rossello
Xavier Rossello
SOSoledad Ojeda
Soledad Ojeda
MPMaría Pilar Portero Pérez
María Pilar Portero Pérez